Epac1 is a guanine nucleotide exchange factor for Rap1 that is activated by direct binding of cAMP. In vitro studies suggest that cAMP relieves the interaction between the regulatory and catalytic domains of Epac. Here we monitor Epac1 activation in vivo by using a CFP-Epac-YFP fusion construct. When expressed in mammalian cells, CFP-Epac-YFP shows significant fluorescence resonance energy transfer (FRET). FRET rapidly decreases in response to the cAMP-raising agents, whereas it fully recovers after addition of cAMP-lowering agonists. Thus, by undergoing a cAMPinduced conformational change, CFP-Epac-YFP serves as a highly sensitive cAMP indicator in vivo.
Introduction
cAMP is a common second messenger that activates protein kinase A (PKA), cyclic nucleotide-regulated ion channels and Epac (for exchange proteins directly activated by cAMP). Epacs are guanine nucleotide exchange factors (GEFs) for Rap1 and Rap2 [1] . Rap GTPases cycle between an inactive GDP-bound and an active GTP-bound state, with GEFs mediating the exchange of GDP for GTP. Rap proteins are involved in a number of biological processes, most notably the regulation of cell adhesion through integrins and cadherins [2] . The GEF Epac1 consists of a C-terminal catalytic domain characteristic for exchange factors for Ras family GTPases and an N-terminal regulatory domain. The latter domain contains a cAMP-binding site similar to those of protein kinase A (PKA) and, in addition, a DEP domain that mediates membrane attachment [3, 4] .
In vitro studies have shown that cAMP is absolutely required for the activation of Epac [5] . It has been hypothesized that the regulatory domain of Epac functions as an auto-inhibitory domain, which is relieved from inhibition by cAMP, but direct proof for this notion is lacking. In this model, Epac is folded in an inactive conformation at low cAMP levels, thereby preventing Rap binding due to steric hindrance. cAMP binding unfolds the protein, allowing Rap to bind. This is somewhat analogous to the mechanism of PKA regulation by cAMP; in its inactive conformation, two regulatory subunits are bound to two catalytic subunits. Upon binding of cAMP this complex falls apart, resulting in the release of active enzymes.
In the present study, we set out to measure Epac activation in vivo by sandwiching Epac between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) and then measure fluorescence resonance energy transfer (FRET) between the two fluorescent moieties. FRET, the radiationless transfer of energy from a fluorescent donor to a suitable acceptor fluorophore, depends on fluorophore orientation and on donor-acceptor distance at a molecular scale. We show that in mammalian cells, CFPEpac-YFP displays significant energy transfer which rapidly diminishes following a rise in intracellular cAMP and increases again in response to a fall in cAMP. This indicates that cAMP causes a significant conformational change in vivo and supports the unfolding model for Epac activation. Taking advantage of this property, we characterized CFPEpac-YFP as a FRET sensor for cAMP and generated cytosolic, catalytically dead mutants. We show that the Epacbased cAMP indicators outperform the previously reported PKA-based cAMP sensor [6] [7] [8] in several aspects.
Results and Discussion cAMP induces a conformational change in Epac
To monitor cAMP-induced conformational changes in Epac, we generated a construct in which Epac1 was fused Nterminally to CFP and C-terminally to YFP, as shown in Fig.1A . Using a GST-RalGDS assay (see supplementary information), it was checked that this construct was able to activate Rap1. CFP-Epac-YFP was transiently expressed in human A431 cells, where it localized to membranes and the cytosol (see further). Fluorescence spectra of these cells revealed significant FRET (Fig. 1B, red line) , indicating that CFP and YFP are in close proximity (~ 3-4 nm). Stimulation with forskolin, a direct activator of adenylyl cyclase, significantly decreased FRET (green line). Similar responses were observed in other cell types, including HEK293, N1E-115 and MCF-7 cells. Thus, cAMP induces a significant conformational change in Epac, in support of the unfolding model (Fig. 1A) .
We next analyzed the kinetics of cAMP-induced FRET changes by ratiometric recording of CFP and YFP emission using a dual-photometer setup (see Methods). Within seconds after addition of forskolin, FRET started to decrease, usually dropping to a minimum level within 2-3 minutes (Fig 1C) . In the presence of the phosphodiesterase inhibitor IBMX (100 μM), forskolin evoked an average decrease . D) Cells were treated with forskolin (25 μM) and IBMX (100 μM) and subsequently permeabilized using digitonin (Digi, 10 μg/ml) in the presence of 2 mM cAMP.
of 30 +/-3 % in CFP/YFP emission ratio. This reflects near-complete saturation of cAMP binding to Epac as deduced from experiments where cells were subsequently permeabilized with digitonin (10 ug/ml) in the presence of 2 mM extracellular cAMP (Fig. 1D ). This caused at most a moderate (on average 3%) further drop in FRET.
Epac activation is independent of subcellular localization CFP-Epac-YFP localized to the cytosol and to membranes, in particular to the nuclear envelope and to perinuclear compartments. We confirmed proper targetting of CFPEpac-YFP by comparing its distribution with that of immunolabeled endogenous Epac in OVCAR3 cells. Identical localization patterns were observed (Zhao et al., in preparation), in agreement with a previous report [9] . Thus, CFP-Epac-YFP can be used as a FRET probe to image Epac activation. As activation of its downstream target Rap1 is membrane-delimited [10, 11] , we set out to visualize Epac activation throughout the cell by two different imaging FRET techniques (see supplementary information). The results reveal that, at least in these cells, agonists induce homogeneous FRET changes throughout the cell. Thus, Epac activation is not confined to membranes, indicating that cAMP binding is the main determinant of Epac activation.
CFP-Epac-YFP as a novel fluorescent cAMP indicator
Having shown that FRET changes in CFP-Epac-YFP reflect cAMP binding, we next investigated how well the Epac construct performs as an in vivo sensor for cAMP. We first tested whether CFP-Epac-YFP is insensitive to cGMP, given that cGMP binds to Epac with an affinity similar to that of cAMP, but fails to activate the enzyme [12] . In N1E-115 neuroblastoma cells, which express soluble guanylyl cyclase, a massive increase in intracellular cGMP levels ensued upon stimulation with the NO-donor sodium nitroprusside, as recorded by the cGMP-sensitive FRET sensor Cygnet-1 [13] . In contrast, the Epac FRET signal was not affected by nitroprusside treatment (Fig. 2A) . We conclude that cGMP does not detectably affect the conformation of Epac. We next tested two cAMP analogues that are specific for either Epac or PKA. As shown in Fig. 2B , the Epac-specific compound 8-p-CPT-2'-O-Me-cAMP [14] reduced FRET in the Epac-, but not in the PKA-cAMP sensor. Conversely, the PKA-specific compound 6-Bnz-cAMP [15] specifically diminished the FRET signal only in cells expressing the PKA-based sensor (Fig. 2B) . Thus, the Epac-cAMP sensor preserves its specificity for cAMP analogues.
We further tested the Epac-FRET construct in various cell types, including Rat-1 and NIH3T3 fibroblasts, mouse GE11 epithelial cells, mouse N1E-115 neuroblastoma and human MCF7 breast carcinoma cells. Addition of various cAMP-raising agents and recep tor agonists, including forskolin, epinephrine, prostaglandin E1 and neurokinin A caused robust FRET decreases in all cases. In general, forskolin induced a sustained decrease in FRET, whereas in most cell types receptor agonists such as PGE1 and epinephrine elicited transient signals lasting for 10-15 minutes ( Fig. 2C and data not shown). The transient nature of the epinephrine-induced signal is due to homologous receptor desen sitization, since a second but distinct stimulus is still capable of decreasing FRET. We conclude that CFP-Epac-YFP is a specific, highly sensitive and reliable indicator of both transient and sustained changes in intracellular cAMP levels. B) The PKA-and the Epac-cAMP sensor were tested for their sensitivity to 8-pCPT-2'-O-Me-cAMP (alias 007; 100 μM), a speci fic activator of Epac, and Benzoyl-cAMP (6-Bnz-cAMP, 1 mM), which specifically activates PKA. In accordance with biochemical data (not shown), the slow and incomplete increases in CFP/YFP ratio in the upper right and lower left panels are caused by limited diffusion of these compounds over the plasma membrane. C) Typical example of an agonist-induced cAMP response recorded with CFP-Epac-YFP in a Rat-1 fibroblast. Epi, epinephrine (250 nM); forskolin (25 μM) was added to calibrate the response.
A catalytically inactive, cytosolic mutant displays increased FRET responses
To generate a cytosolic variant, we next deleted the DEP domain (aa 1-148), which is the main determinant of membrane DEP)-YFP, located almost exclusively to the cytosol ( Fig. 3A) in HEK293δlocalization [16, 17] . Indeed, this chimera, CFP-Epac( and other cells. This mutation also diminished Epacs ability to activate Rap1 significantly (see supplementary information). We further introduced mutations (T781A, F782A) to render the indicator catalytically dead. These residues were predicted to affect Rap1-binding based on the crystal structure of SOS, a closely related GEF [18] . The resulting construct, CFP-Epac(DDEP-CD)-YFP displayed no detectable Rap1 activation (see supplementary information).
Spectral analysis revealed that the basal FRET level in the cytosolic variants was significantly above that of the full-length chimera (Fig. 3B) . FRET in CFP-Epac(DDEP-CD)-YFP expressing cells reliably decreased upon stimulation with cAMP-raising agonists. Importantly, maximal changes in CFP/YFP ratio outper formed that of the full-length chimera by approximately 50% in magnitude (~45% versus ~30%), significantly increasing the signal-to-noise ratio (Fig 3C) . Because selectivity remained unaltered as compared to CFP-Epac-YFP (not shown), the cytosolic localization, catalytic inactivity and improved signal-to-noise ratio make CFP-Epac(DDEP-CD)-YFP the indicator of choice for monitoring cytosolic cAMP levels.
Epac-based cAMP sensors display an extended dynamic range
Previously described PKA-based cAMP sensors are tetramers consisting of two catalytic and two regulatory domains. These probes contain four cAMP binding sites and have submicromolar (~300 nM) affinity in vivo [19] . cAMP binding in PKA displays coope rativity with an apparent Hill coefficient of 1.6 [20] . As a consequence, this probe has a steep dose-response relationship that rapidly reaches saturation. In contrast, in vitro studies have shown that the affinity of the single cAMP binding site in Epac is at least an order of magnitude lower [21] . We determined the affinities of the different fluorescent Epac constructs for cAMP in vitro by fluorescence ratiometry (see supplementary information). The results revealed affinities of ~50, ~35 and ~14 mM for CFP-Epac-YFP, CFP-Epac(DDEP-CD)-YFP, respectively. Thus, the Epac-cAMP sensors should display right-shifted and extended dynamicδDEP)-YFP and CFP-Epac ( ranges.
To test this notion in vivo, cells expressing either CFP-Epac-YFP or the PKA-cAMP sensor were cocultured on coverslips and neighboring cells expressing comparable amounts of Epac and PKA, respectively, were analyzed for FRET changes. Dosed photorelease of NPE-cAMP, a membrane-permeable caged cAMP analogue, was used to evoke identical incremental changes in intracellular cAMP in the two neighbor cells (Fig. 4A) . Sequential increases in cAMP caused a rapid decrease in FRET and subsequent apparent saturation of the response in the PKA sensor, whereas the Epac sensor showed a much larger dynamic range. In line with these observations, the responses to forskolin-induced robust cAMP increases (Fig 4B) were rapid and saturating for the PKA-based sensor, whereas FRET in the Epac-based sensor changed more gradually and often did not saturate completely (Fig. 1D) .
The shifted and extended dynamic range of Epac for cAMP has important consequences for measuring physiological cAMP levels. As shown in Fig. 4C , in GE11 cells isoproterenol triggers a rapid and rather sustained FRET change (~ 30%). In isoproterenol-pretreated cells, addition of lysophosphatidic acid (LPA) resulted in a rapid recovery of the FRET signal, as one would expect for a Gi-coupled receptor agonist that lowers cAMP levels [22] . Of note, the PKA-based sensor failed to record this rapid effect of LPA, apparently due to saturation of the probe, but rather reported a substantial lag period (up to several minutes; Fig. 4C , middle trace). That it fails to record the true kinetics of the LPA-induced cAMP response becomes evident when the Epac-based sensor is used. As is shown in Fig. 4C , CFP-Epac-YFP detects the initial fall in cAMP levels within seconds after LPA addition. 
Conclusions
Our results support a model in which cAMP binding to the regulatory domain of Epac releases an inhibitory conformation that prevents binding to Rap1 [23] . Importantly, the FRET signal not only reflects binding of cAMP but also activation of Epac because cGMP, which binds with a similar affinity but fails to activate Epac [24] is without effect. We employed this property to show that the local, membrane-delimited activation of Rap-1 [25, 26] is not due to local activation of Epac. The here observed uniform Epac activation contrasts with the findings of Zaccolo and Pozzan (2000) who detected subcellular cAMP gradients in cardiac myocytes with the PKA-based cAMP sensor. This is likely explained by cell-type specific differences in activity and intracellular distribution of the phosphodiesterases that shape such cAMP gradients, because we failed to detect gradients of cAMP using the PKA probe in our cells.
Of note, our in vivo data based on photolysis of NPEcaged cAMP (Fig. 4A ) strongly support the notion that cAMP differentially regulates its effectors, i.e. low cAMP concentrations signal mainly via PKA, while at higher doses cAMP exerts additional effects via Epac activation [27] .
This study further shows that Epac-based FRET constructs are ideally suited as cAMP sensors in that they display improved characteristics compared to the commonly used PKA-based sensors. First, the moderate affinities of our Epac constructs (14 to 50 μM) result in a right-shifted dose-response relationship that matches physiological cAMP levels (Fig. 4) . During review of this manuscript, a K d of 2.3 μM was reported for a FRET sensor based on The Epac-cAMP sensor exhibits an extended dynamic range as compared to the PKA-cAMP sensor A) Flash photolysis (thin arrows, 1/15 sec; thick arrows, 1/4 sec) of NPE-caged cAMP in neighboring A431 cells expressing either PKA-cAMP sensor or Epac-cAMP sensor (as recognized by partial decoration of membranes). Forskolin (50 μM) was added to further increase cAMP levels. Traces are normalized for comparison. B) Typical responses to forskolin (50 μM), recorded with the PKA-and the Epac-cAMP sensor in A431 cells. 10-90% response rise times differed significantly (34 ± 5 s for PKA, n=9; 248 ± 38 s for Epac, n=9; p<0.005). Note the sharp transition from the dynamic response range to the saturated plateau phase in the PKA sensor trace. C) Upper trace, sustained cAMP elevation evoked by isoproterenol (10 μM) in a GE11 epithelial cell. Middle and lower traces, registration of cAMP decreases induced by subsequent addition of LPA (5 μM), visualized with the PKA probe and the Epac probe, respectively. Note that Epac reveals the immediate LPA effect, whereas it is obscured by saturation of the PKA-cAMP sensor.
Epacs isolated cAMP-binding domain [28] . Thus, Epacbased sensors provide a wide range of affinities which allows matching the sensors to the anticipated cAMP levels. Second, the PKA regulatory subunits contain two cAMP binding sites each that exhibit cooperative binding (Hill coefficient of 1.6) resulting in a very steep response. In contrast, the single cAMP binding domain of Epac1 results in an extended dynamic range. Third, Epac needs only a single cAMP molecule for a ~30% FRET change while four molecules of cAMP are needed to cause a comparable change in two donor-acceptor pairs in PKA. Together with the lower affinity of Epac, this results in reduced buffering of cytosolic cAMP. This is not trivial since expression levels of cytosolic FRET probes commonly are in the micromolar range (0.1-5 μM [29] ), i.e. at cAMP levels found in the cytosol upon receptor stimulation. Fourth, the Epac-cAMP sensor is a single polypeptide, eliminating expressionand stoichiometry-related problems encountered with the PKA-based versions. For instance, imbalanced expression levels of regulatory and catalytic subunits of PKA hampers quantitative analyses of FRET changes. Furthermore, a single cDNA construct allows easy generation of stably transfected cell lines, which is often a problem with the PKA-based sensor (unpublished observations). Fifth, monomeric Epac sensors show faster activation kinetics than the slowly dissociating PKA-based sensors [30] . In addition, the cytosolic CFP-Epac(δDEP-CD)-YFP construct exhibits even larger cAMP-induced FRET changes, resulting in a superior signal-to-noise ratio. Together, these properties make Epac-based FRET probes the preferred fluorescent indicators for monitoring elevated cAMP levels in living cells.
Methods Materials
Isoproterenol, 1-oleoyl-LPA, prostaglandin E1, epinephrine and sodium nitroprusside were from Sigma Chemical Co. (St. Louis, MO); IBMX , forskolin, and neurokinin A were from Calbiochem-Novabiochem Corp. (La Jolla, CA); 1-(2-nitrophenyl)ethyl adenosine-3',-5'-cyclic monophosphate (NPE-caged cAMP) was from Molecular Probes Inc. (Eugene, OR); 8-p-CPT-2'-O-Me-cAMP and N 6 -Benzoyladenosine-3',-5'-cyclic monophosphate were kindly provided by Hans Gottfried Genieser (Biolog Life Sciences (Bremen, Germany).
DNA Constructs
eCFP ("non-sticky", A206K [1] ), a multiple cloning site with BglII/EcoRV/NheI/SacI restriction sites, and eYFP (A206K) were cloned in-frame, and inserted in pCDNA3 (Invitrogen) using HindIII/XbaI. Full-length Epac1 was generated by PCR using human Epac1 (#AF103905) and cloned inframe into the restriction sites EcoRV/NheI of the MCS using the primers 5'-TTGATATCTGAT GGTGTTGAGAAG-GATGCACC-3' and 5'-GGGGCTAGCTGGCTCCAGCTCT-CGG G-3'. The resultant construct contained the linker SGLRSRYL, separating eCFP from Epac1, and ASEL, separating Epac1 from eYFP.
CFP-Epac1(δDEP)-YFP was generated using the upstream primer 5'-TTGATATCAGC CCGTG GGAAC TCA TG-3' instead, deleting aa 1-148. The latter construct was rendered catalytically dead (CFP-Epac1(δDEP-CD)-YFP) by pointmutating T781A and F782A in the GEF domain. The chosen residues were predicted to affect Rap1-binding based on the crystal structure of the Son of Sevenless (SOS) protein, a GEF for H-Ras and a close family member of Epac [2] .
The PKA-based cAMP sensor, consisting of two expression vectors encoding the YFP-tagged catalytic and CFP-tagged regulatory domain of PKA, was as published [3, 4] . The FRET-sensor for cGMP, termed Cygnet-2.1 for cyclic GMP indicator using energy transfer, consists of a truncated form of the cGMP-dependent protein kinase sandwiched between CFP and YFP and was used as published [5] .
Cell Culture, transfections and live cell experiments
Cells were seeded on glass coverslips, cultured, and transfected with constructs as described [31] . Experiments were performed in a culture chamber mounted on an inverted microscope in bicarbonate-buffered saline (containing, in mM, 140 NaCl, 5 KCl, 1 MgCl 2 , 1 CaCl 2 , 10 glucose, 23 NaHCO 3 , with 10 mM HEPES added), pH 7.2, kept under 5% CO 2 , at 37°C. Agonists and inhibitors were added from concentrated stocks. Expression levels of fluorescent probes were estimated as described [32] .
Dynamic FRET monitoring
Cells on coverslips were placed on an inverted NIKON Microscope and excited at 425 nm. Emission of CFP and YFP was detected simultaneously through 470 +/-20 and 530 +/-25 nm bandpass filters. Data were digitized and FRET was expressed as ratio of CFP to YFP signals, the value of which was set to 1.0 at the onset of the experiments. Changes are expressed as percent deviation from this initial value of 1.0.
Loading And Flash Photolysis of NPE-caged cAMP
Cells were loaded by incubation with 100 μM NPE-caged cAMP for 15 min. Uncaging was with brief pulses of UV light (340-410 nm) from a 100 W HBO lamp using a shutter. For comparison, traces were normalized with respect to baseline and final FRET values.
Confocal FRET imaging
We recently described FRET imaging by sensitized emission on a Leica TCS-SP2 confocal microscope (Mannheim, Germany) in detail [6] . Briefly, reference cells expressing only CFP or YFP were seeded together with the CFPEpac-YFP expressing cells and simultaneously imaged in the same field of view. Three images were collected: the donor image (CFP, excited at 430 nm and detected from 460-510 nm), sensitized emission image (YFP, excited at 430nm and detected from 528-603 nm) and the acceptor image (YFP, excited at 514 nm and detected from 528-603 nm). All images were shading-corrected. Donor leakthrough in the sensitized emission channel and false acceptor excitation that occured at 430nm were corrected using correction factors derived from the reference cells as descibed [7] . Fret efficiency was expressed by dividing the sensitized emission image with the donor image.
Fluorescence spectra were recorded with the λ-scan functionality of the Leica confocal microscope from living cells, excited at 430 nm. Spectra are the mean of 10 scans from different cells.
Fluorescence Lifetime Imaging.
FLIM experiments were performed on a Leica inverted DM-IRE2 microscope equipped with Lambert Instruments (Leutingewolde, the Netherlands) frequency domain lifetime attachment, controlled by the vendors EZflim software. CFP was excited with ~4 mW of 430 nm light from a LED modulated at 40 MHz and emission was collected at 450-490 nm using an intensified CCD camera. Calculated CFP lifetimes were referenced to a 1 μM solution of Rhodamine-G6 in medium, set at 4.11 ns lifetime. CFPEpac-YFP expressing cells were cocultured with reference cells that expressed CFP only.
Supplemental Figures
Different fluorescently tagged Epac constructs were tested for their guanine exchange activity towards Rap1. Indicated constructs were transfected in NIH3T3 cells, which do not express detectable amounts of endogenous Epac1. After 48 hours, cells were stimulated with 100 μM 8-p-CPT-2'-O-MecAMP for 15 min. Cells were lysed and assayed for GTP-bound Rap1 using GST-RalGDS as an activation-specific probe [1] . Upper panel, pull-down samples were probed with an antibody against Rap1 (Santa Cruz, SC-65). The upper band is HA-tagged Rap1, the lower band is endogenous Rap1. Middle panel, expression of HA-Rap1 as detected with an anti-HA monoclonal antibody (12CA5). Lower panel, expression of Epac1 constructs was verified using an Epac1 specific mouse monoclonal antibody (5D3). Note that, in line with the reported dependence of Epac on correct subcellular localization, loss of the DEP domain significantly interferes with Rap activation. Residual activity is completely lost in CFPEpac1(ΔDEP-CD)-YFP, the mutant that lacks Rap1 binding.
Activation of the downstream target of Epac1, Rap1, reportedly is membrane-delimited, but conflicting views exist on whether this predominantly occurs at endomembranes or at the plasma membrane [2, 3] . We therefore set out to visualize Epac activation throughout the cell by two different FRET techniques. Initially, we confirmed that tagging of Epac with GFPs does not interfere with its proper localization by comparing the cellular distribution of CFP-Epac-YFP to that of immunolabeled endogenous Epac in OVCAR3 cells. In good agreement with published data for untagged Epac [4] , CFP-Epac-YFP localized in the cytosol as well as to membranes (the nuclear envelope, perinuclear membranes, and to a lesser extent the plasma membrane).
Widefield Fluorescence Lifetime IMaging (FLIM; see Methods) reports FRET quan ti tatively as a decrease in the excited-state lifetime of the fluorescent donor molecule. For reference, A431 cells expressing CFP-Epac-YFP were imaged along with HEK293 control cells expressing cytosolic CFP. In resting cells, our FLIM analysis failed to reveal spatial differences in FRET efficiency ( Fig. 2A, left  panel) . Furthermore, activa tion of Epac with cAMP-raising agonists caused a similar FRET decrease throughout the cells (Fig. 2A, right panel) .
To better resolve subcellular details, we employed a recently developed, highly corrected confocal laser scanning FRET microscopy approach [5] that allows discrimination of CFP-Epac-YFP activation in the cytosol and at membranes. In the cell types studied, Epac activation state as deduced from FRET did not depend on membrane localization (lower left panel). cAMP-raising agonists such as epinephrine (250 nM) caused similar FRET changes at membranes and in the cytosol (lower right panel). The homogeneous FRET values determined for CFP-Epac-YFP throughout the cells are likely due to the rapid diffusion of cAMP in the cytosol. Taken together, our data demonstrate that Epac1 activation is not localized to membranes and further indicate that binding to cAMP is the main determinant of Epac activation. 
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Suppl fig 2.
Epac activation is independent of subcellular localization
Suppl Fig 1. In vivo guanine nucleotide exchange (GEF) activity of Epac-based FRET probes
To determine dissociation constants (K d ) towards cAMP, five 15-cm petridishes of HEK293 cells were transfected for each of the constructs. Cells were harvested 24h post transfection, washed in PBS and homogenized in hypotonic medium (PBS:H2O, 1:2) with a Downs piston. The homogenate was cleared by high-speed centrifugation for 10 minutes and subsequently ionic concentrations were corrected towards intracellular levels (in mM: 140 KCl, 5 NaCl, 1 MgCl 2 and 10 HEPES for pH 7.2). FRET changes caused by consecutive additions of cAMP were recorded in the stirred cuvet of a PTI Quantamaster dual channel spectrofluorimeter (Lawrenceville, NJ). FRET was expressed as the ratio of the YFP channel (530 +/-10 nm) and the CFP channel (490 +/-10 nm), when excited at 420 +/-3 nm. For analysis, we used the Hill-function: 
